Risk perception after CF carrier testing and impact of the test result on reproductive decision making
- 14 April 1997
- journal article
- research article
- Published by Wiley in American Journal of Medical Genetics
- Vol. 69 (4) , 422-428
- https://doi.org/10.1002/(sici)1096-8628(19970414)69:4<422::aid-ajmg17>3.0.co;2-p
Abstract
A correct interpretation of the result of a CF carrier test and a correct understanding of the risk of having a CF child is complicated by the limited sensitivity of the DNA test. The present paper addresses this problem, with special attention for the residual risk after a negative test result. Secondly, the impact of the test results on child bearing decisions is evaluated. Seventy percent of a sample of 200 subjects tested in the Center for Human Genetics in Leuven answered a mailed questionnaire and participated in an interview. Knowledge about the recessive transmission of CF was weak. In the case of both partners receiving a negative test result, more than half the subjects were not aware of the restrictions of DNA testing, and were convinced that there was no residual risk. Two thirds of the subjects from the ‘carrier + negative test result couples’ were aware of the residual risk of having a CF child. This risk did not hamper further reproduction. Carriers who were single or whose partner was not tested, had much difficulties to understand the risk. Although most of them had no idea about their exact risk level, it influenced their childbearing decisions to some extent. It was also shown that the own risk of having a CF child had an impact on attitudes toward reproduction in hypothetical situations with different risk levels. Am. J. Med. Genet. 69:422–428, 1997.Keywords
This publication has 16 references indexed in Scilit:
- The CF carrier status is not associated with a diminished self‐concept or increased anxiety: results of psychometric testing after at least 1 yearClinical Genetics, 1996
- Barriers to carrier testing for adult cystic fibrosis sibs: The importance of not knowingAmerican Journal of Medical Genetics, 1995
- A stigmatizing effect of the carrier status for cystic fibrosis?Clinical Genetics, 1994
- The impact of population based screening for carriers of cystic fibrosis.Journal of Medical Genetics, 1994
- Prenatal diagnosis of Smith–Lemli–Opitz syndrome, type IIAmerican Journal of Medical Genetics, 1994
- Detection of 98.5% of the mutations in 200 Belgian cystic fibrosis alleles by reverse dot-blot and sequencing of the complete coding region and exon/intron junctions of the CFTR geneGenomics, 1993
- The spectrum of cystic fibrosis mutationsTrends in Genetics, 1992
- Prenatal screening for cystic fibrosisThe Lancet, 1992
- Psychological and social consequences of community carrier screening programme for cystic fibrosisThe Lancet, 1992
- Optimistic Biases About Personal RisksScience, 1989